Hershel Bhadsavle, MD
Critical Care Medicine · Jasper, GANPI 1568881639
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,345 of the $7,955 with a category attached, or 79.8%. 31 manufacturers reported payments, led by Medtronic at 34.3% of the total. Among critical care medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $31.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- GSK$935
- Boehringer Ingelheim$895
- Grifols USA, LLC$629
- AstraZeneca$431
- Takeda Pharmaceuticals U.S.A., Inc.$401
- plus $2K from 25 others
What the payments were for
- Travel & lodging$1,61020%
- Food & beverage$6,34580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $2,730 |
| GSK | 48 | $935 |
| Boehringer Ingelheim | 41 | $895 |
| Grifols USA, LLC | 24 | $629 |
| AstraZeneca | 21 | $431 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $401 |
| Regeneron Healthcare Solutions, Inc. | 10 | $345 |
| Mylan Specialty L.p. | 14 | $310 |
| Baxter Healthcare | 10 | $224 |
| Sanofi | 5 | $163 |
| Verona Pharma, Inc. | 5 | $105 |
| Body Vision Medical Inc. | 1 | $97 |
| Viatris Specialty LLC | 4 | $91 |
| 3b Medical, Inc. | 1 | $79 |
| Insmed, Inc. | 3 | $66 |
| Harmony Biosciences LLC | 2 | $53 |
| Fisher & Paykel Healthcare Inc | 3 | $52 |
| Novartis | 2 | $36 |
| Merck | 1 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Resmed Corp | 2 | $32 |
| AbbVie | 2 | $31 |
| Portola Pharmaceuticals, LLC | 2 | $29 |
| La Jolla Pharmaceutical Company | 1 | $27 |
| Olympus America Inc. | 1 | $26 |
| Ambu Inc. | 1 | $23 |
| Acacia Pharma Inc | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $17 |
| Amgen | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Breas Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUMISITE$2,316
- Arcpoint$125
- NUCALA$104
How this compares
$7,955 in reported general payments places this provider in the 90th percentile of 265 critical care medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 333 | $246,360 |
| OfevNintedanib Esylate | 11 | $148,219 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $27,677 |
| EliquisApixaban | 40 | $26,979 |
| Breo ElliptaFluticasone/Vilanterol | 50 | $25,583 |
| Spiriva HandihalerTiotropium Bromide | 26 | $19,552 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 28 | $17,517 |
| SymbicortBudesonide/Formoterol Fumarate | 59 | $16,701 |
| Spiriva RespimatTiotropium Bromide | 12 | $14,127 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 44 | $9,669 |
| Incruse ElliptaUmeclidinium Bromide | 15 | $7,686 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 169 | $5,838 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 18 | $3,463 |
| Arnuity ElliptaFluticasone Furoate | 13 | $3,174 |
| Wixela InhubFluticasone Propion/Salmeterol | 38 | $3,031 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $935 | $300,319439 claims |
| Boehringer IngelheimOfev, Spiriva Respimat | $895 | $162,34523 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $431 | $44,37889 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 265 critical care medicine providers in Georgia.
Other critical care medicine in Jasper
- Salman FidahusseinLagrange$852K
- Bruce FriedmanAugusta$629K
- Gregory MauldinSnellville$221K
- Ramzy RimawiAtlanta$72K
- Rafael Alba YunenBrunswick$58K
- April McDonaldGainesville$41K
- Matthew SchmittAtlanta$32K
- Prasad GarimellaBraselton$20K
- James PalazzoloAlbany$16K
- Ramana RaoAlbany$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.